MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$2,898,763
EPS
-$0.58
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2024-09-30
2024-06-30
2024-03-31
Selling and marketing expense
--5,000 -
General and administrative expenses
-173,073 239,028 269,456
Share based compensation
-96,888 611,570 -
Professional services expense
-431,304 864,588 1,180,499
Amortization expense
-250,000 250,000 250,000
Salary expense
-378,740 459,099 445,359
Research and development expense
-811,784 398,817 777,069
Operating expenses
-2,141,789 2,828,102 2,922,383
Operating income (loss)
--2,141,789 -2,828,102 -2,922,383
Change in fair value of derivative liability warrants
-349,500 -149,250 34,875
Disposal group, not discontinued operation, loss (gain) on write-down
-37,257 --
Other income (expense)
-51,558 8,063 86,625
Interest expense
--66,056 -
Interest expense, nonoperating
-50,926 -200,505
Nonoperating income (expense)
-312,875 -207,243 -79,005
Provision for income taxes
0 ---
Income (loss) from continuing operations before income taxes, noncontrolling interest
--1,828,914 -3,035,345 -3,001,388
Net loss attributable to common stockholders
-2,739,403 ---
Net income (loss), including portion attributable to noncontrolling interest
--1,828,914 -3,035,345 -
Net loss attributable to non-controlling interests
159,360 ---
Net loss
-2,898,763 -1,828,914 -3,035,345 -3,001,388
Loss per share, basic
-0.58 -0.05 -0.08 -0.08
Loss per share, fully diluted
-0.58 -0.05 -0.08 -0.08
Weighted average number of common shares outstanding, basic
4,745,089 39,806,505 37,569,312 35,544,709
Weighted average number of common shares outstanding, diluted
4,745,089 39,806,505 37,569,312 35,544,709
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,898,763 Net lossattributable to...$159,360 Net lossattributable to common...-$2,739,403

Coeptis Therapeutics Holdings, Inc. (COEP)

Coeptis Therapeutics Holdings, Inc. (COEP)